Abstract
Purpose
The aim of this article is to review the published literature on the use of bleomycin, ethanol and sodium tetradecyl sulfate as sclerosing embolic agents in vascular malformation management and contrast and compare them.
Material and methods
Published journal articles on bleomycin, ethanol and sodium tetradecyl sulfate employed in vascular malformation management were reviewed and the results were analyzed.
Results
While efficacy has been described for all the sclerosing embolic agents, absolute ethanol appears to be superior compared to others in that cures were routinely documented.
Conclusion
Absolute ethanol is highly effective in the permanent eradication and permanent ablation of high-flow and low-flow vascular malformations.
Zusammenfassung
Zweck
Das Ziel dieses Beitrags ist es, die publizierte Literatur zur Anwendung von Bleomycin, Ethanol und Natriumtetradecylsulfat als sklerosierende Wirkstoffe zur Behandlung vaskulärer Malformationen gegenüberzustellen und zu vergleichen.
Material und Methoden
Es wurden die Ergebnisse publizierter Beiträge zu Bleomycin, Ethanol und Natriumtetradecylsulfat zur Behandlung vaskulärer Malformationen analysiert.
Ergebnisse
Während die Wirksamkeit für alle sklerosierenden Embolisationswirkstoffe beschrieben wurde, scheint reines Ethanol im Vergleich zu anderen Wirkstoffen überlegen zu sein.
Schlussfolgerung
Reines Ethanol ist hochwirksam für die langfristige Eradikation und permanente Ablation von High-flow- und Low-flow-Gefäßmalformationen.
Similar content being viewed by others
References
White RI Jr., Pollak J, Persing J, Henderson KJ, Thomson JG, Burdge CM (2000) Long-term outcome of embolotherapy and surgery for high-flow extremity arteriovenous malformations. J Vasc Interv Radiol 11:1285–1295
Zanetti PH, Sherman FE (1972) Experimental evaluation of a tissue adhesive as an agent for the treatment of aneurysms and arteriovenous anomalies. J Neurosurg 36:72–79
Kerber C (1976) Balloon catheter with a calibrated leak. A new system for superselective angiography and occlusive catheter therapy. Radiology 120:547–550
Bank WO, Kerber CW, Cromwell LD (1981) Treatment of intracerebral arteriovenous malformations with isobutyl 2‑cyanoacrylate: initial clinical experience. Radiology 139:609–616
Ellman BA, Parkhill BJ, Curry TS 3rd, Marcus PB, Peters PC (1981) Ablation of renal tumors with absolute ethanol: a new technique. Radiology 141:619–626
Ellman BA, Green CE, Eigenbrodt E, Garriott JC, Curry TS (1980) Renal infarction with absolute ethanol. Invest Radiol 15:318–322
Yakes WF (2015) Use of multiple Sclerosant agents in vascular malformation management: a world in Endovascular confusion and chaos. J Vasc Interv Radiol 26:1494–1496
Ul Haq F, Mitchell SE, Tekes A, Weiss CR (2015) Bleomycin foam treatment of venous malformations: a promising agent for effective treatment with minimal swelling. J Vasc Interv Radiol 26:1484–1493
Hassan Y, Osman AK, Altyeb A (2013) Noninvasive management of hemangioma and vascular malformation using intralesional bleomycin injection. Ann Plast Surg 70:70–73
Sainsbury DC, Kessell G, Fall AJ, Hampton FJ, Guhan A, Muir T (2011) Intralesional bleomycin injection treatment for vascular birthmarks: a 5-year experience at a single United Kingdom unit. Plast Reconstr Surg 127:2031–2044
Bai Y, Jia J, Huang XX, Alsharif MJ, Zhao JH, Zhao YF (2009) Sclerotherapy of microcystic lymphatic malformations in oral and facial regions. J Oral Maxillofac Surg 67:251–256
Shigematsu T, Sorscher M, Dier EC, Berenstein A (2018) Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy. J Neurointerv Surg. https://doi.org/10.1136/neurintsurg-2018-013813
Zhang J, Li HB, Zhou SY et al (2013) Comparison between absolute ethanol and bleomycin for the treatment of venous malformation in children. Exp Ther Med 6:305–309
Spence J, Krings T, TerBrugge KG, Agid R (2011) Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy. Head Neck 33:125–130
Mendez-Echevarria A, Fernandez-Prieto A, de la Serna O et al (2018) Acute lung toxicity after Intralesional Bleomycin Sclerotherapy. Pediatrics. https://doi.org/10.1542/peds.2016-1787
Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH (2003) Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg 37:533–538
Johnson PL, Eckard DA, Brecheisen MA, Girod DA, Tsue TT (2002) Percutaneous ethanol sclerotherapy of venous malformations of the tongue. Ajnr Am J Neuroradiol 23:779–782
Su L, Fan X, Zheng L, Zheng J (2010) Absolute ethanol sclerotherapy for venous malformations in the face and neck. J Oral Maxillofac Surg 68:1622–1627
Orlando JL, Caldas JG, Campos HG, Nishinari K, Wolosker N (2010) Outpatient percutaneous treatment of deep venous malformations using pure ethanol at low doses under local anesthesia. Clinics (Sao Paulo) 65:837–840
Lee IH, Kim KH, Jeon P et al (2009) Ethanol sclerotherapy for the management of craniofacial venous malformations: the interim results. Korean J Radiol 10:269–276
Vogelzang RL, Atassi R, Vouche M, Resnick S, Salem R (2014) Ethanol embolotherapy of vascular malformations: clinical outcomes at a single center. J Vasc Interv Radiol 25:206–213 (quiz 14)
Ali S, Weiss CR, Sinha A, Eng J, Mitchell SE (2016) The treatment of venous malformations with percutaneous sclerotherapy at a single academic medical center. Phlebology 31:603–609
Guevara CJ, Gonzalez-Araiza G, Kim SK, Sheybani E, Darcy MD (2016) Sclerotherapy of diffuse and Infiltrative venous malformations of the hand and distal forearm. Cardiovasc Intervent Radiol 39:705–710
Teusch VI, Wohlgemuth WA, Hammer S et al (2017) Ethanol-gel Sclerotherapy of venous malformations: effectiveness and safety. Ajr Am J Roentgenol 209:1390–1395
Wang D, Su L, Han Y et al (2017) Direct intralesional ethanol sclerotherapy of extensive venous malformations with oropharyngeal involvement after a temporary tracheotomy in the head and neck: Initial results. Head Neck 39:288–296
Park HS, Do YS, Park KB et al (2016) Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations. Eur Radiol 26:1301–1310
Colletti G, Deganello A, Bardazzi A et al (2017) Complications after treatment of head and neck venous malformations with sodium Tetradecyl sulfate foam. J Craniofac Surg 28:e388–e392
Kothary N, Soulen MC, Clark TW et al (2005) Renal angiomyolipoma: long-term results after arterial embolization. J Vasc Interv Radiol 16:45–50
Bakal CW, Cynamon J, Lakritz PS, Sprayregen S (1993) Value of preoperative renal artery embolization in reducing blood transfusion requirements during nephrectomy for renal cell carcinoma. J Vasc Interv Radiol 4:727–731
Mukund A, Gamanagatti S (2010) Ethanol ablation of renal cell carcinoma for palliation of symptoms in advanced disease. J Palliat Med 13:117–120
Usuki N, Nakamura K, Takashima S et al (1994) Embolization of varicocele with ethanol]. Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiol 54:870–875
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
F. E. V. Rohlffs and W. F. J. Yakes declare that they have no competing interests.
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Rohlffs, F., Yakes, W.F. Review of bleomycin, ethanol and sodium tetradecyl sulfate as sclerosant agents in vascular malformations. Gefässchirurgie 23, 502–506 (2018). https://doi.org/10.1007/s00772-018-0461-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00772-018-0461-1
Keywords
- Sodium tetradecyl sulfate
- Sclerosing agents
- Lymphatic malformations
- Arteriovenous malformations
- Embolotherapy
- Ethanol
- Venous malformations